Clinical trials
Neuroblastoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 1 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 9 |
| 2025 | 6 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
| Unknown status | 6 |
| Not yet recruiting | 4 |
| Completed | 4 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 4 |
| Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 4 |
| Nanjing First Hospital, Nanjing Medical University | 2 |
| Sichuan University | 2 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2 |
| Sun Yat-Sen University Cancer Center | 2 |
| Affiliated Hospital of Nantong University | 1 |
| Ascentage Pharma Group Inc. | 1 |
| Beijing Biotech | 1 |
| Beijing Children's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroblastoma | 37 |
| Recurrence | 6 |
| Wilms Tumor | 6 |
| Hepatoblastoma | 3 |
| Lymphoma | 3 |
| Medulloblastoma | 3 |
| Neoplasm Metastasis | 2 |
| Paraganglioma | 2 |
| Pheochromocytoma | 2 |
| Rhabdomyosarcoma | 2 |
Trials
Showing 26 to 37 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.